How do airplanes fly? An aerospace engineer explains the physics of flight 
Spacesuits need a major upgrade for the next phase of exploration 
Could a telescope ever see the beginning of time? An astronomer explains 
The rising flood of space junk is a risk to us on Earth – and governments are on the hook 
What is minoxidil, the anti-balding hair growth treatment? Here’s what the science says 
Why now is the time to address humanity’s impact on the moon 
Alpha, beta, theta: what are brain states and brain waves? And can we control them? 
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects 
Why is the universe ripping itself apart? A new study of exploding stars shows dark energy may be more complicated than we thought 
Genetic diseases: How scientists are working to make DNA repair (almost) a piece of cake 
Six space missions to look forward to in 2024 
Synthetic human embryos let researchers study early development while sidestepping ethical and logistical hurdles 
Dark energy is one of the biggest puzzles in science and we're now a step closer to understanding it 
A Nasa rover has reached a promising place to search for fossilised life on Mars 
Scientists around the world are exploring various angles to further understand HIV/AIDS and find a cure. Several research grants were previously awarded to groups who are aiming to focus on post-treatment control.
The Foundation for AIDS Research (amfAR) recently announced in a press release that five grants were confirmed by the institution to support the study of “the mechanisms and predictors of post-treatment control.” According to AIDSMap.com, post-treatment controllers are HIV/AIDS patients who eventually stopped receiving treatments.
These patients have also received treatments via antiretroviral therapy upon getting diagnosed with HIV/AIDS. After achieving an immense decrease to an undetectable status of viral load, post-treatment controllers decide to stop receiving treatment altogether with their immune system positively adjusting to it.
In a statement, amfAR CEO Kevin Robert Frost said, “Post-treatment controllers may hold the key to understanding how the immune system naturally controls the virus, so it’s essential that we achieve a fuller understanding of what mediates post-treatment control. It’s also vital that we improve our knowledge of the crucial differences in the viral reservoir that may exist in those hit hardest by the epidemic.”
A couple of grantees focusing on post-treatment controllers are Dr. Jonathan Li and Dr. Godwin Nchinda from Boston and Cameroon, respectively. Dr. Li will reportedly begin his research with “an impressive cohort of post-treatment controllers from one of the largest HIV clinical trial networks in the world.” On the other hand, Dr. Nchinda gathered women who were pregnant while undergoing ART and are successful post-treatment controllers after giving birth.
Despite the availability of various treatments, unfortunately, the world has yet to find a complete cure for HIV/AIDS, thus, it continues to be one of the largest epidemics around the world. In the last quarter of 2018, it was reported that 37 million people worldwide have been diagnosed with HIV and 2.6 million of them are ages 15 years and below.
